Department of Sociology, Indiana University, Bloomington, IN, USA.
Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.
Addiction. 2020 Dec;115(12):2317-2326. doi: 10.1111/add.15069. Epub 2020 Apr 20.
Our ability to combat the opioid epidemic depends, in part, on dismantling the stigma that surrounds drug use. However, this epidemic has been unique and, to date, we have not understood the nature of public prejudices associated with it. Here, we examine the nature and magnitude of public stigma toward prescription opioid use disorder (OUD) using the only nationally representative data available on this topic.
General Social Survey (GSS), a cross-sectional, nationally representative survey of public attitudes.
United States, 2018.
PARTICIPANTS/CASES: A total of 1169 US residents recruited using a probability sample.
Respondents completed a vignette-based survey experiment to assess public stigma toward people who develop OUD following prescription of opioid analgesics. This condition is compared with depression, schizophrenia, alcohol use disorder (AUD) and subclinical distress using multivariable logistic or linear regression.
Adjusting for covariates (e.g. race, age, gender), US residents were significantly more likely to label symptoms of OUD a physical illness [73%, confidence interval (CI) = 66-80%; P < 0.001] relative to all other conditions, and less likely to label OUD a mental illness (40%, CI = 32-48%; P < 0.001). OUD was significantly less likely to be attributed to bad character (37%, CI = 30-44%; P < 0.001) or poor upbringing (17%, CI = 12-23%; P < 0.001) compared with AUD. Nonetheless, perceptions of competence associated with OUD (e.g. ability to manage money; 41%, CI = 33-49%; P < 0.01) were lower than AUD, depression and subclinical distress. Moreover, willingness to socially exclude people with OUD was very high (e.g. 76% of respondents do not want to work with a person with OUD), paralleling findings on traditional targets of strong stigma (i.e. AUD and schizophrenia).
US residents do not typically hold people with prescription opioid use disorder responsible for their addiction, but they express high levels of willingness to subject them to social exclusion.
我们对抗阿片类药物泛滥的能力在一定程度上取决于消除围绕吸毒的污名。然而,这场泛滥是独特的,迄今为止,我们还没有理解与之相关的公众偏见的性质。在这里,我们使用唯一的全国代表性数据来研究处方类阿片药物使用障碍(OUD)的公众污名的性质和程度。
横断面、全国代表性的公众态度调查——综合社会调查(GSS)。
美国,2018 年。
参与者/病例:使用概率样本招募的总共 1169 名美国居民。
受访者完成了一项基于情景的调查实验,以评估人们在服用阿片类止痛药后发展为 OUD 时所产生的公众污名。与抑郁、精神分裂症、酒精使用障碍(AUD)和亚临床困扰相比,使用多变量逻辑或线性回归比较这种情况。
在调整了协变量(例如种族、年龄、性别)后,与其他所有情况相比,美国居民更有可能将 OUD 的症状标记为身体疾病[73%,置信区间(CI)=66-80%;P<0.001],而不太可能将 OUD 标记为精神疾病(40%,CI=32-48%;P<0.001)。与 AUD 相比,OUD 归因于不良性格(37%,CI=30-44%;P<0.001)或不良教养(17%,CI=12-23%;P<0.001)的可能性明显较低。尽管如此,与 AUD、抑郁和亚临床困扰相比,与 OUD 相关的能力感知(例如管理金钱的能力;41%,CI=33-49%;P<0.01)较低。此外,拒绝与 OUD 患者交往的意愿非常高(例如,76%的受访者不想与 OUD 患者一起工作),与传统的强烈污名目标(即 AUD 和精神分裂症)相吻合。
美国居民通常不会认为有处方类阿片药物使用障碍的人应对他们的成瘾负责,但他们表示非常愿意将他们置于社会排斥之外。